相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predicting With Confidence: Using Conformal Prediction in Drug Discovery
Jonathan Alvarsson et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry
Henrik Carlsson et al.
METABOLOMICS (2020)
Metabolomics in multiple sclerosis disease course and progression
Pavan Bhargava et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Untargeted metabolomic analysis of plasma from relapsing-remitting multiple sclerosis patients reveals changes in metabolites associated with structural changes in brain
Duncan A. Sylvestre et al.
BRAIN RESEARCH (2020)
A blood-based metabolomics test to distinguish relapsing-remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application
Tianrong Yeo et al.
SCIENTIFIC REPORTS (2020)
Interoperable and scalable data analysis with microservices: applications in metabolomics
Payam Emami Khoonsari et al.
BIOINFORMATICS (2019)
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
Stephanie Herman et al.
CELLS (2019)
Altered Cerebrospinal Fluid Concentrations of Hydrophobic and Hydrophilic Compounds in Early Stages of Multiple Sclerosis-Metabolic Profile Analyses
A. Podlecka-Pietowska et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2019)
A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis
Maureen Wentling et al.
BRAIN (2019)
Metabolome-based signature of disease pathology in MS
S. L. Andersen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Multiple sclerosis has a distinct lipid signature in plasma and cerebrospinal fluid
Enedina Maria Lobato de Oliveira et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2019)
Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes
Pavan Bhargava et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Targeted metabolomics approach for identification of relapsing-remitting multiple sclerosis markers and evaluation of diagnostic models
Marat F. Kasakin et al.
MEDCHEMCOMM (2019)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
Stephanie Herman et al.
THERANOSTICS (2018)
Intrathecal treatment trial of rituximab in progressive MS An open-label phase 1b study
Joakim Bergman et al.
NEUROLOGY (2018)
Mass spectrometry based metabolomics for in vitro systems pharmacology: pitfalls, challenges, and computational solutions
Stephanie Herman et al.
METABOLOMICS (2017)
Mechanism of action of three newly registered drugs for multiple sclerosis treatment
Kaja Kasarello et al.
PHARMACOLOGICAL REPORTS (2017)
Molecular-based diagnosis of multiple sclerosis and its progressive stage
Christopher Barbour et al.
ANNALS OF NEUROLOGY (2017)
Defining secondary progressive multiple sclerosis
Johannes Lorscheider et al.
BRAIN (2016)
OpenMS: a flexible open-source software platform for mass spectrometry data analysis
Hannes L. Roest et al.
NATURE METHODS (2016)
MetFrag relaunched: incorporating strategies beyond in silico fragmentation
Christoph Ruttkies et al.
JOURNAL OF CHEMINFORMATICS (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis
Mariana Lopez-Gongora et al.
PLOS ONE (2015)
Searching molecular structure databases with tandem mass spectra using CSI:FingerID
Kai Duehrkop et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons
Jae-Ick Kim et al.
SCIENCE (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
Amit Bar-Or et al.
DRUGS (2014)
Introducing Conformal Prediction in Predictive Modeling. A Transparent and Flexible Alternative to Applicability Domain Determination
Ulf Norinder et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Metabolites from Liquid Chromatography-Mass Spectrometry Data
Erhan Kenar et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis
S. N. Reinke et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
An Automated Pipeline for High-Throughput Label-Free Quantitative Proteomics
Hendrik Weisser et al.
JOURNAL OF PROTEOME RESEARCH (2013)
CAMERA: An Integrated Strategy for Compound Spectra Extraction and Annotation of Liquid Chromatography/Mass Spectrometry Data Sets
Carsten Kuhl et al.
ANALYTICAL CHEMISTRY (2012)
A cross-platform toolkit for mass spectrometry and proteomics
Matthew C. Chambers et al.
NATURE BIOTECHNOLOGY (2012)
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis
Marek J. Noga et al.
METABOLOMICS (2012)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Glutamate receptors in neuroinflammatory demyelinating disease
Christopher Bolton et al.
MEDIATORS OF INFLAMMATION (2006)
QSAR applicability domain estimation by projection of the training set in descriptor space: A review
J Jaworska et al.
ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2005)
fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis
C Mainero et al.
NEUROIMAGE (2004)
分享论文
